The immune system's fight against the Coronavirus; convalescent plasma from Covid-19 survivors may be used to treat patients and protect those at risk
Botany Department, Industrial Biotechnology Program, Faculty of Science, Tanta University, Tanta, Egypt.
Review Article
World Journal of Advanced Research and Reviews, 2020, 06(03), 102-109
Article DOI: 10.30574/wjarr.2020.6.3.0186
Publication history:
Received on 04 June 2020; revised on 12 June 2020; accepted on 14 June 2020
Abstract:
Severe Acute Respiratory Syndrome (SARS) and Coronavirus (Covid-19) outbreak are creating emergency in public health sector. Using antiviral, antimalarial and vaccine are still under investigations, so Convalescent plasma therapy for Covid-19 is a current option because it has been succeeded in other Coronaviruses before. This work will discuss what is the Covid-19? What is the source of Covid-19? Is it transmitted from animal to human? And will discuss the convalescent plasma (CP) as a therapy for Covid-19.
Keywords:
SARS; COVID-19; Convalescent Plasma Therapy; SARS-CoV-2; Neutralizing antibodies; ACE-2 receptor; Coronavirus
Full text article in PDF:
Copyright information:
Copyright © 2020 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0